malondialdehyde has been researched along with mexiletine in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Altinoz, E; Ates, O; Cayli, SR; Durak, A; Kocak, A; Tarim, O; Turkoz, Y; Yologlu, S; Yucel, N | 1 |
| Batcioglu, K; Demirtas, H; Djamgoz, MB; Guzel, RM; Onkal, R; Satilmis, B; Uyumlu, AB; Yildirim, B; Yucel, N | 1 |
2 other study(ies) available for malondialdehyde and mexiletine
| Article | Year |
|---|---|
Neuroprotective effect of mexiletine in the central nervous system of diabetic rats.
Topics: Animals; Blood Glucose; Brain Stem; Central Nervous System; Cerebellum; Cerebral Cortex; Diabetes Mellitus, Experimental; Hippocampus; Injections, Intraperitoneal; Male; Malondialdehyde; Mexiletine; Neuroprotective Agents; Nitric Oxide; Rats; Rats, Wistar; Spinal Cord; Time Factors; Xanthine Oxidase | 2006 |
Oxidative stress in the in vivo DMBA rat model of breast cancer: suppression by a voltage-gated sodium channel inhibitor (RS100642).
Topics: 9,10-Dimethyl-1,2-benzanthracene; Animals; Disease Models, Animal; Female; Glutathione Peroxidase; Malondialdehyde; Mammary Neoplasms, Experimental; Mexiletine; Oxidative Stress; Rats; Rats, Sprague-Dawley; Signal Transduction; Sodium Channel Blockers; Superoxide Dismutase | 2012 |